Clinical Trial: Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Ototoxicity, Drug-Induced
Study Type: INTERVENTIONAL
Official Title: Cisplatin and Sodium Thiosulfate Otoprotection With or Without SAHA/Vorinostat Histone Deacetylase Inhibition for Relapsed/Refractory Hepatoblastoma and Other Embryonal Tumors
Brief Summary:
This study will attempt to demonstrate the efficacy of Sodium Thiosulfate (STS) in preventing hearing loss in patients re-treated with cisplatin-based therapy according to regimens Cisplatin and STS (regimen CS) and Cisplatin, STS and Vorinostat/SAHA (regimen CSS).
Read more